Sale

Endometriosis Treatment Market

Global Endometriosis Treatment Market Share, Size, Growth, Analysis, Forecast: By Indication Type: Superficial Peritoneal Lesion, Endometrioma, Deeply Infiltrating Endometriosis, Others; By Diagnostic Method: Ultrasound, Others; By Treatment Method; By Drug Class; By Distribution Channel; Regional Analysis; Supplier Landscape; 2024-2032

Global Endometriosis Treatment Market Outlook

The global endometriosis treatment market size was estimated to be worth USD 1.55 billion in 2023. The market is expected to grow at a CAGR of 7.7% during the forecast period of 2024-2032 to attain a market value of USD 3.02 billion by 2032. The growth of the market is driven by the rising research and development activities.

 

Endometriosis Treatment Market: Introduction

Endometriosis is a medical condition in which the tissue lining the uterus grows outside the uterus, causing pain and discomfort. The condition is often associated with infertility, and it affects millions of women worldwide. The global endometriosis treatment market is highly competitive, with key players focusing on research and development activities to develop innovative products and strengthen their market position.

 

endometriosis treatment market

Read more about this reportREQUEST FREE SAMPLE COPY IN PDF

 

Endometriosis Epidemiology

Endometriosis is a common medical condition that affects women of reproductive age. It is estimated that approximately 10% of women worldwide are affected by endometriosis. The condition occurs when the tissue lining the uterus (endometrium) grows outside the uterus, leading to pain and discomfort.

 

Endometriosis is often misdiagnosed or undiagnosed, which leads to delayed diagnosis and treatment. The exact cause of endometriosis is unknown, but it is believed to be a combination of genetic and environmental factors. It is also more common among women who have never had children. Endometriosis can affect various parts of the body, including the ovaries, fallopian tubes, and the tissue lining the pelvis. The most common symptoms of endometriosis include pelvic pain, painful periods, pain during intercourse, and infertility.

 

The prevalence of endometriosis varies by region and age group. According to a systematic review and meta-analysis published in The Lancet in 2020, the global prevalence of endometriosis was estimated to be 1.7% (95% CI 1.5-1.9) among women of reproductive age. The prevalence was found to be highest in North America (2.6%, 95% CI 2.2-3.0) and lowest in Africa (1.0%, 95% CI 0.5-1.5).

 

The same study also found that the prevalence of endometriosis increased with age, peaking in women in their 40s. It was also found to be more common among women with infertility, chronic pelvic pain, and dysmenorrhea (painful periods).

 

Endometriosis Treatment Market Segmentations

The market can be categorised into indication type, diagnostic method, treatment method, drug class, and distribution channel.

 

endometriosis treatment market by segments

Read more about this reportREQUEST FREE SAMPLE COPY IN PDF

 

Market Breakup by Indication Type

  • Superficial Peritoneal Lesion
  • Endometrioma
  • Deeply Infiltrating Endometriosis
  • Others

 

Market Breakup by Diagnostic Method

  • Ultrasound
  • Pelvic Examination
  • Laparoscopy
  • Magnetic Resonance Imaging
  • Others

 

Market Breakup by Treatment Method

  • Hormonal Therapy
  • Pain Management
  • Others

 

Endometriosis Treatment Market Breakup by Drug Class

  • Oral Contraceptives
  • Progestins
  • NSAIDs
  • GnRH Analogues
  • Others

 

Market Breakup by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

 

Endometriosis Treatment Market Breakup by Region

  • North America
    • United States of America
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others

 

endometriosis treatment market by region

Read more about this reportREQUEST FREE SAMPLE COPY IN PDF

 

Endometriosis Treatment Market Scenario

The global endometriosis treatment market is expected to witness significant growth during the forecast period of 2024-2032. The market is being driven by factors such as the increasing prevalence of endometriosis, growing awareness and diagnosis of the condition, and the availability of advanced treatments and therapies.

 

Hormonal therapy is the most commonly used treatment for endometriosis, followed by non-steroidal anti-inflammatory drugs (NSAIDs), gonadotropin-releasing hormone (GnRH) agonists, aromatase inhibitors, and progestins. Laparoscopy is the most common diagnostic method used to diagnose endometriosis.

 

North America dominates the endometriosis treatment market, followed by Europe and the Asia Pacific. The market in North America is driven by the high prevalence of endometriosis and the availability of advanced healthcare infrastructure. The market in Europe is also expected to grow significantly, with key players focusing on research and development activities to develop innovative products. The market in the Asia Pacific region is expected to grow at the highest CAGR during the forecast period, owing to the increasing awareness about endometriosis and the rising healthcare expenditure in the region.

 

Key Players in the Global Endometriosis Treatment Market

The report gives an in-depth analysis of the key players involved in the Endometriosis Treatment market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:

 

  • Abbott
  • AbbVie Inc.
  • Bayer AG
  • Pfizer Inc.
  • Ipsen Pharma
  • Evotec SE
  • Myovant Sciences GmbH
  • Philogen S.p.A.
  • Astellas Pharma Inc.
  • Orphagen Pharmaceuticals

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Indication Type
  • Diagnostic Method
  • Treatment Method
  • Drug Class
  • Distribution Channel
  • Region
Breakup by Indication Type
  • Superficial Peritoneal Lesion
  • Endometrioma
  • Deeply Infiltrating Endometriosis
  • Others
Breakup by Diagnostic Method
  • Ultrasound
  • Pelvic Examination
  • Laparoscopy
  • Magnetic Resonance Imaging
  • Others
Breakup by Treatment Method
  • Hormonal Therapy
  • Pain Management
  • Others
Breakup by Drug Class
  • Oral Contraceptives
  • Progestins
  • NSAIDs
  • GnRH Analogues
  • Others
Breakup by Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
  • Industry Events, Initiatives, and Trends
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Abbott
  • AbbVie Inc.
  • Bayer AG
  • Pfizer Inc.
  • Ipsen Pharma
  • Evotec SE
  • Myovant Sciences GmbH
  • Philogen S.p.A.
  • Astellas Pharma Inc.
  • Orphagen Pharmaceuticals

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
2    Research Methodology
3    Executive Summary
4    Endometriosis Overview 

    4.1    Guidelines and Stages
    4.2    Pathophysiology
    4.3    Screening and Diagnosis
    4.4    Treatment Pathway 
5    Patient Profile
    5.1    Patient Profile Overview
    5.2    Patient Psychology and Emotional Impact Factors
    5.3    Risk Assessment and Treatment Success Rate
6    Current Scenario Evaluation and Regulatory Framework
    6.1    Emerging Therapies and Clinical Trials
    6.2    Patent Landscape 
        6.2.1    Patent Overview
            6.2.1.1    Patent Status and Expiry
            6.2.1.2    Timelines from Drug Development to Commercial Launch
            6.2.1.3    New Drug Application
                6.2.1.3.1    Documentation and Approval Process
    6.3    Cost of Treatment
    6.4    Regulatory Framework
        6.4.1    Regulatory Overview
            6.4.1.1    US FDA
            6.4.1.2    EU EMA
            6.4.1.3    INDIA CDSCO
            6.4.1.4    JAPAN PMDA
            6.4.1.5    Others
7    Challenges and Unmet Needs
    7.1    Treatment Pathway Challenges
    7.2    Compliance and Drop-Out Analysis
    7.3    Awareness and Prevention Gaps
8    Global Endometriosis Treatment Market
    8.1    Global Endometriosis Treatment Market Overview
    8.2    Global Endometriosis Treatment Market Analysis 
        8.2.1    Market Overview
            8.2.1.1    Global Endometriosis Treatment Market Historical Value (2017-2023) 
            8.2.1.2    Global Endometriosis Treatment Market Forecast Value (2024-2032)
        8.2.2    Global Endometriosis Treatment Market by Indication Type
            8.2.2.1    Market Overview
                8.2.2.1.1    Superficial Peritoneal Lesion
                8.2.2.1.2    Endometrioma
                8.2.2.1.3    Deeply Infiltrating Endometriosis
                8.2.2.1.4    Others
        8.2.3    Global Endometriosis Treatment Market by Diagnostic Method
            8.2.3.1    Market Overview
                8.2.3.1.1    Ultrasound
                8.2.3.1.2    Pelvic Examination
                8.2.3.1.3    Laparoscopy
                8.2.3.1.4    Magnetic Resonance Imaging
                8.2.3.1.5    Others  
        8.2.4    Global Endometriosis Treatment Market by Treatment Method
            8.2.4.1    Market Overview
                8.2.4.1.1    Hormonal Therapy
                8.2.4.1.2    Pain Management
                8.2.4.1.3    Others
        8.2.5    Global Endometriosis Treatment Market by Drug Class
            8.2.5.1.1    Oral Contraceptives
            8.2.5.1.2    Progestins
            8.2.5.1.3    NSAIDs
            8.2.5.1.4    GnRH Analogues
            8.2.5.1.5    Others
        8.2.6    Global Endometriosis Treatment Market by Distribution Channel
            8.2.6.1    Market Overview
                8.2.6.1.1    Hospital Pharmacies
                8.2.6.1.2    Retail Pharmacies
                8.2.6.1.3    Online Pharmacies
        8.2.7    Global Endometriosis Treatment Market by Region
            8.2.7.1    Market Overview
                8.2.7.1.1    North America 
                8.2.7.1.2    Europe
                8.2.7.1.3    Asia Pacific
                8.2.7.1.4    Latin America
                8.2.7.1.5    Middle East and Africa
9    North America  Endometriosis Treatment Market
    9.1    Market Share by Country
    9.2    United States of America
        9.2.1    Historical Trend (2017-2023)
        9.2.2    Forecast Trend (2024-2032)
    9.3    Canada
        9.3.1    Historical Trend (2017-2023)
        9.3.2    Forecast Trend (2024-2032)
10    Europe Endometriosis Treatment Market
    10.1    Market Share by Country
    10.2    United Kingdom
        10.2.1    Historical Trend (2017-2023)
        10.2.2    Forecast Trend (2024-2032)
    10.3    Germany
        10.3.1    Historical Trend (2017-2023)
        10.3.2    Forecast Trend (2024-2032)
    10.4    France
        10.4.1    Historical Trend (2017-2023)
        10.4.2    Forecast Trend (2024-2032)
    10.5    Italy
        10.5.1    Historical Trend (2017-2023)
        10.5.2    Forecast Trend (2024-2032)
    10.6    Others
11    Asia Pacific Endometriosis Treatment Market
    11.1    Market Share by Country
    11.2    China
        11.2.1    Historical Trend (2017-2023)
        11.2.2    Forecast Trend (2024-2032)
    11.3    Japan
        11.3.1    Historical Trend (2017-2023)
        11.3.2    Forecast Trend (2024-2032)
    11.4    India
        11.4.1    Historical Trend (2017-2023)
        11.4.2    Forecast Trend (2024-2032)
    11.5    ASEAN
        11.5.1    Historical Trend (2017-2023)
        11.5.2    Forecast Trend (2024-2032)
    11.6    Australia
        11.6.1    Historical Trend (2017-2023)
        11.6.2    Forecast Trend (2024-2032)
    11.7    Others
12    Latin America Endometriosis Treatment Market
    12.1    Market Share by Country
    12.2    Brazil
        12.2.1    Historical Trend (2017-2023)
        12.2.2    Forecast Trend (2024-2032)
    12.3    Argentina
        12.3.1    Historical Trend (2017-2023)
        12.3.2    Forecast Trend (2024-2032)
    12.4    Mexico
        12.4.1    Historical Trend (2017-2023)
        12.4.2    Forecast Trend (2024-2032)
    12.5    Others
13    Middle East and Africa Endometriosis Treatment Market
    13.1    Market Share by Country
    13.2    Saudi Arabia
        13.2.1    Historical Trend (2017-2023)
        13.2.2    Forecast Trend (2024-2032)
    13.3    United Arab Emirates
        13.3.1    Historical Trend (2017-2023)
        13.3.2    Forecast Trend (2024-2032)
    13.4    Nigeria
        13.4.1    Historical Trend (2017-2023)
        13.4.2    Forecast Trend (2024-2032)
    13.5    South Africa
        13.5.1    Historical Trend (2017-2023)
        13.5.2    Forecast Trend (2024-2032)
    13.6    Others
14    Global Endometriosis Treatment Market Dynamics
    14.1    Market Drivers and Constraints
    14.2    SWOT Analysis
    14.3    Porter’s Five Forces Model 
    14.4    Key Demand Indicators 
    14.5    Key Price Indicators 
    14.6    Industry Events, Initiatives, and Trends 
    14.7    Value Chain Analysis
15    Supplier Landscape
    15.1    Abbott
        15.1.1    Company Overview
        15.1.2    Product Portfolio
        15.1.3    Demographic Reach and Achievements
        15.1.4    Mergers and Acquisitions
        15.1.5    Certifications
    15.2    AbbVie Inc.
        15.2.1    Company Overview
        15.2.2    Product Portfolio
        15.2.3    Demographic Reach and Achievements
        15.2.4    Mergers and Acquisitions
        15.2.5    Certifications
    15.3    Bayer AG
        15.3.1    Company Overview
        15.3.2    Product Portfolio
        15.3.3    Demographic Reach and Achievements
        15.3.4    Mergers and Acquisitions
        15.3.5    Certifications
    15.4    Pfizer Inc.
        15.4.1    Company Overview
        15.4.2    Product Portfolio
        15.4.3    Demographic Reach and Achievements
        15.4.4    Mergers and Acquisitions
        15.4.5    Certifications
    15.5    Ipsen Pharma
        15.5.1    Company Overview
        15.5.2    Product Portfolio
        15.5.3    Demographic Reach and Achievements
        15.5.4    Mergers and Acquisitions
        15.5.5    Certifications
    15.6    Evotec SE
        15.6.1    Company Overview
        15.6.2    Product Portfolio
        15.6.3    Demographic Reach and Achievements
        15.6.4    Mergers and Acquisitions
        15.6.5    Certifications
    15.7    Myovant Sciences GmbH 
        15.7.1    Company Overview
        15.7.2    Product Portfolio
        15.7.3    Demographic Reach and Achievements
        15.7.4    Mergers and Acquisitions
        15.7.5    Certifications
    15.8    Philogen S.p.A.
        15.8.1    Company Overview
        15.8.2    Product Portfolio
        15.8.3    Demographic Reach and Achievements
        15.8.4    Mergers and Acquisitions
        15.8.5    Certifications
    15.9    Astellas Pharma Inc.
        15.9.1    Company Overview
        15.9.2    Product Portfolio
        15.9.3    Demographic Reach and Achievements
        15.9.4    Mergers and Acquisitions
        15.9.5    Certifications
    15.10    Orphagen Pharmaceuticals
        15.10.1    Company Overview
        15.10.2    Product Portfolio
        15.10.3    Demographic Reach and Achievements
        15.10.4    Mergers and Acquisitions
        15.10.5    Certifications
16    Global Endometriosis Treatment Market- Drugs Distribution Model (Additional Insight)
    16.1    Overview 
    16.2    Potential Distributors 
    16.3    Key Parameters for Distribution Partner Assessment
17    Payment Methods (Additional Insight)
    17.1    Government Funded
    17.2    Private Insurance
    17.3    Out-of-Pocket

 

*Additional insights provided are customizable as per client requirements.

Key Questions Answered in the Report

The endometriosis market attained a value of nearly USD 1.55 billion in 2023.

The market is projected to grow at a CAGR of 7.7% during the forecast period of 2024-2032.

The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach USD 3.02 billion by 2032.

The growth of the market is driven by factors like rising cases of endometriosis due to the rising issues in women of reproductive age and the rising awareness about the disease.

The rapid advancements and developments in the market acts as a key trend for the market.

The indications of the disease include superficial peritoneal lesion, endometrioma, and deeply infiltrating endometriosis, among others.

The diagnostic methods include ultrasound, pelvic examination, laparoscopy, and magnetic resonance imaging, among others.

The treatment methods include hormonal therapy and pain management, among others.

The drugs include oral contraceptives, progestins, NSAIDs, and GnRH analogues, among others.

The distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies.

The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest share of the market.

The key players in the market include Abbott, AbbVie Inc., Bayer AG, Pfizer Inc., Ipsen Pharma, Evotec SE, Myovant Sciences GmbH, Philogen S.p.A., Astellas Pharma Inc., and Orphagen Pharmaceuticals, among others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER